Discover the groundbreaking effects of GLP1 receptor agonists in treating diabetes and promoting weight loss, and learn about the challenges in drug approval and insurance coverage.
Bloomberg News Health Reporter Madison Muller discusses how the drug Ozempic could cut demand for big-money drugs targeting a wide range of maladies, even Alzheimer’s. Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.